Marshall Wace’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-27,197
Closed -$1.74M 2977
2025
Q1
$1.74M Buy
+27,197
New +$1.74M ﹤0.01% 1433
2024
Q4
Sell
-42,938
Closed -$5.36M 2783
2024
Q3
$5.36M Sell
42,938
-397
-0.9% -$49.6K 0.01% 893
2024
Q2
$6.85M Buy
43,335
+39,992
+1,196% +$6.32M 0.01% 798
2024
Q1
$433K Buy
+3,343
New +$433K ﹤0.01% 1746
2023
Q4
Sell
-245,928
Closed -$29.8M 2272
2023
Q3
$29.8M Buy
245,928
+186,886
+317% +$22.7M 0.06% 302
2023
Q2
$6.76M Sell
59,042
-120,217
-67% -$13.8M 0.01% 781
2023
Q1
$24.7M Sell
179,259
-6,746
-4% -$930K 0.05% 337
2022
Q4
$24.1M Buy
+186,005
New +$24.1M 0.05% 349
2022
Q1
Sell
-503,638
Closed -$45.4M 3271
2021
Q4
$45.4M Buy
503,638
+500,289
+14,938% +$45.1M 0.08% 222
2021
Q3
$310K Sell
3,349
-16,170
-83% -$1.5M ﹤0.01% 2060
2021
Q2
$1.52M Sell
19,519
-3,617
-16% -$281K 0.01% 1248
2021
Q1
$1.73M Buy
+23,136
New +$1.73M 0.01% 1196
2019
Q4
Sell
-24,153
Closed -$1.82M 1978
2019
Q3
$1.82M Buy
+24,153
New +$1.82M 0.01% 760
2019
Q2
Sell
-5,967
Closed -$711K 1777
2019
Q1
$711K Sell
5,967
-4,439
-43% -$529K 0.01% 1027
2018
Q4
$1.14M Buy
+10,406
New +$1.14M 0.01% 873
2018
Q3
Sell
-3,667
Closed -$485K 1270
2018
Q2
$485K Sell
3,667
-4,321
-54% -$571K 0.01% 579
2018
Q1
$592K Buy
7,988
+1,845
+30% +$137K 0.02% 331
2017
Q4
$342K Sell
6,143
-21,670
-78% -$1.21M 0.01% 337
2017
Q3
$1.25M Buy
+27,813
New +$1.25M 0.06% 201
2016
Q4
Hold
0
1107
2016
Q3
Hold
0
1117
2015
Q2
Sell
-11,296
Closed -$150K 1036
2015
Q1
$150K Buy
+11,296
New +$150K ﹤0.01% 760